CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending President Murmu presides over AGM of Indian Red Cross Society RML hospital performs 24 plastic surgeries in 24 hours Yashoda Medicity introduces India’s First Elekta Unity MR Linac with Integrated CMM Latest Delhi Govt Vs Doctors: LG orders to dissolve Delhi Medical Council GNF partners with Tamil Nadu Apex Skill Development Centre As Covid rises, Centre asks States to ensure availability of oxygen, isolation beds, ventilators India’s active COVID-19 cases crosses 4,000 mark, 5 deaths in 24 hrs
